US and European registries are changing the image of Fibromuscular Dysplasia (FMD) from a rare, curable cause of renovascular hypertension mostly occurring in young women to a more common, diffuse, usually benign but sometimes devastating vascular disease, which may occur at all ages of life, both in men and women.
International collaborative efforts are currently underway to unravel the genetics, pathophysiology and natural history of the disease, standardize diagnosis and management, and identify biomarkers and predictors of adverse vascular outcomes.
This meeting will bring together leading international experts of FMD and related vascular diseases who will summarize current knowledge on FMD, present cutting edge research and identify clinical challenges and research priorities for the next years. It may interest nephrologists, neurologists, cardiologists, internists, paediatricians, radiologists, vascular medicine specialists, as well as basic and clinical researchers.